Which of our best loved and safest blue chips are riskier than you think?

Goldman Sachs is warning that buying expensive defensive stocks like CSL Limited (ASX: CSL) and Sydney Airport Holdings Limited (ASX: SYD) now carries more risk than you'd think even though the strategy has been a winner over the past 20 years.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

We have a long-standing love affair with blue chip stocks that have defensible and predictable earnings. These stocks tend to be characterised by relatively low share price volatility and dependable cash flow generation – all the necessary ingredients that make them an ideal addition to any portfolio.

This is one reason why the share prices of the likes of biotherapeutics company CSL Limited (ASX: CSL), airport operator Sydney Airport Holdings Limited (ASX: SYD) and shopping centre operator Westfield Corp Ltd (ASX: WFD) trade at a significant premium to the market. After all, you have to cough up for quality.

If you had any doubt about the handsome returns you can make from paying a premium for such stocks, often affectionately referred to as "expensive defensives", data from Goldman Sachs will make you a convert.

The broker said its strategy of buying and shorting 40 stocks on the ASX 200 (Index:^AXJO) (ASX:XJO) with the lowest and highest share price volatility has produced an average annual return of 15% a year since 1996. This means you could have generated this handsome return if you bought blue chips that displayed the lowest four-year share price volatility and shorted those with the highest volatility.

Shorting refers to selling stock you borrowed in the hope of buying it back at a lower price to pocket the difference.

This strategy has worked very well over the past 20 years but Goldman Sachs thinks the tide is turning and this strategy is unlikely to work going forward because it believes our "safest" blue chip stocks now hold as much risk as the most volatile stocks in the S&P/ASX 200!

It isn't the high valuation of the low volatility blue chips that has prompted the warning – it's the prospect of rising interest rates. You see, low interest rates have provided a very strong tailwind for the expensive defensives and the group is currently trading on a forward price-earnings multiple of 18.6 times, which is 20% ahead of their long-term average.

"At the same time, the beta (a measure of price volatility relative to the market) of the most volatile stocks in the index has dropped well below previous troughs," said Goldman Sachs.

"For the first time in our history of data, 'low vol' stocks have just as much 'market risk' as their 'high vol' peers."

The broker thinks the market is underestimating the risk posed by rising global interest rates, which seems to have taken over from "growth" as the key systematic risk in the market.

I don't necessarily agree with the view from an Australian perspective due to poor wage growth, structural issues in the retail sector and lacklustre corporate profit growth. But this is certainly a risk we cannot afford to ignore as experience has taught me that no one strategy can work all the time in any market.

Other expensive defensives that Goldman Sachs think are at risk include hospital operator Ramsay Health Care Limited (ASX: RHC), packaging company Amcor Limited (ASX: AMC), AusNet Services (ASX: AST), gas pipeline owner APA Group (ASX: APA) and Investa Office Fund (ASX: IOF).

However, this isn't to say there are no other buying opportunities worth considering at this current point. Click below to get some great stock ideas from the experts at the Motley Fool.

Motley Fool contributor Brendon Lau has no position in any stocks mentioned. The Motley Fool Australia owns shares of Sydney Airport Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »